Postdoctoral Fellow Inhibiting Nemo-like Kinase for Treatment of DBA

The Role of RSK in normal hematopoiesis and myeloid leukemogenesis

Postdoctoral Fellow (Wakatsuki Lab, SLAC and Bio-X), Development of CREB Inhibitors for treatment of Acute Leukemia

Instructor Normal and Aberrant Erythropoiesis

Medicinal Chemist, ChEM-H, Drug Development

Medical Student, University of Minnesota School of Medicine, Niclosamide for Treatment of AML

Undergraduate Student, University of Pennsylvania, Regulation of p53 by Nemo-like Kinase

Undergraduate Student, Stanford University, Targeting Nemo-like Kinase in Diamond Blackfan Anemia

Life Science Research Professional, Mechanisms of drug resistance in AML

Structural Biology of CREB:CBP and identification of inhibitors